List of Excipients in API bromocriptine mesylate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing bromocriptine mesylate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Validus Pharmaceuticals LLC | PARLODEL | bromocriptine mesylate | 30698-202 | LACTOSE | |
| Validus Pharmaceuticals LLC | PARLODEL | bromocriptine mesylate | 30698-202 | MAGNESIUM STEARATE | |
| Validus Pharmaceuticals LLC | PARLODEL | bromocriptine mesylate | 30698-202 | MALEIC ACID | |
| Validus Pharmaceuticals LLC | PARLODEL | bromocriptine mesylate | 30698-202 | POVIDONE | |
| Validus Pharmaceuticals LLC | PARLODEL | bromocriptine mesylate | 30698-202 | SILICON DIOXIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing bromocriptine mesylate
Detailed excipient profiles for bromocriptine mesylate
Excipient focus: ALCOHOL
bromocriptine mesylate drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Lifesciences Limited | bromocriptine mesylate | 65841-654 |
| >Company | >Ingredient | >NDC |
bromocriptine mesylate drug variants not containing ALCOHOL
Excipient focus: AMMONIA
bromocriptine mesylate drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Lifesciences Limited | bromocriptine mesylate | 65841-654 |
| Zydus Pharmaceuticals USA Inc | bromocriptine mesylate | 68382-110 |
| >Company | >Ingredient | >NDC |
bromocriptine mesylate drug variants not containing AMMONIA
Excipient focus: ANHYDROUS LACTOSE
bromocriptine mesylate drug variants containing ANHYDROUS LACTOSE
bromocriptine mesylate drug variants not containing ANHYDROUS LACTOSE
Excipient focus: BUTYL ALCOHOL
bromocriptine mesylate drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | bromocriptine mesylate | 0378-7096 |
| Zydus Lifesciences Limited | bromocriptine mesylate | 65841-654 |
| >Company | >Ingredient | >NDC |
bromocriptine mesylate drug variants not containing BUTYL ALCOHOL
Excipient focus: CARRAGEENAN
bromocriptine mesylate drug variants containing CARRAGEENAN
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Lifesciences Limited | bromocriptine mesylate | 65841-654 |
| Zydus Pharmaceuticals USA Inc | bromocriptine mesylate | 68382-110 |
| >Company | >Ingredient | >NDC |
bromocriptine mesylate drug variants not containing CARRAGEENAN
Excipient focus: CITRIC ACID MONOHYDRATE
bromocriptine mesylate drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Santarus Inc | bromocriptine mesylate | 68012-258 |
| VEROSCIENCE LLC | bromocriptine mesylate | 73515-123 |
| >Company | >Ingredient | >NDC |
bromocriptine mesylate drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: D&C YELLOW NO. 10
bromocriptine mesylate drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | bromocriptine mesylate | 0378-7096 |
| >Company | >Ingredient | >NDC |
bromocriptine mesylate drug variants not containing D&C YELLOW NO. 10
Excipient focus: EDETATE DISODIUM
bromocriptine mesylate drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | bromocriptine mesylate | 0378-2042 |
| Sandoz Inc | bromocriptine mesylate | 0781-5325 |
| Physicians Total Care Inc | bromocriptine mesylate | 54868-5667 |
| American Health Packaging | bromocriptine mesylate | 60687-286 |
| >Company | >Ingredient | >NDC |
bromocriptine mesylate drug variants not containing EDETATE DISODIUM
Excipient focus: FD&C BLUE NO. 1
bromocriptine mesylate drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | bromocriptine mesylate | 0378-7096 |
| >Company | >Ingredient | >NDC |
bromocriptine mesylate drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
bromocriptine mesylate drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | bromocriptine mesylate | 0378-7096 |
| >Company | >Ingredient | >NDC |
bromocriptine mesylate drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C RED NO. 40
bromocriptine mesylate drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | bromocriptine mesylate | 0378-7096 |
| >Company | >Ingredient | >NDC |
bromocriptine mesylate drug variants not containing FD&C RED NO. 40
Excipient focus: FERRIC OXIDE RED
bromocriptine mesylate drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | bromocriptine mesylate | 0378-7096 |
| Zydus Lifesciences Limited | bromocriptine mesylate | 65841-654 |
| Zydus Pharmaceuticals USA Inc | bromocriptine mesylate | 68382-110 |
| >Company | >Ingredient | >NDC |
bromocriptine mesylate drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
bromocriptine mesylate drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | bromocriptine mesylate | 0378-7096 |
| >Company | >Ingredient | >NDC |
bromocriptine mesylate drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
bromocriptine mesylate drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | bromocriptine mesylate | 0378-7096 |
| Zydus Lifesciences Limited | bromocriptine mesylate | 65841-654 |
| Zydus Pharmaceuticals USA Inc | bromocriptine mesylate | 68382-110 |
| >Company | >Ingredient | >NDC |
bromocriptine mesylate drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
bromocriptine mesylate drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | bromocriptine mesylate | 0378-7096 |
| >Company | >Ingredient | >NDC |
bromocriptine mesylate drug variants not containing GELATIN
Excipient focus: HYPROMELLOSE 2910
bromocriptine mesylate drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Lifesciences Limited | bromocriptine mesylate | 65841-654 |
| Zydus Pharmaceuticals USA Inc | bromocriptine mesylate | 68382-110 |
| >Company | >Ingredient | >NDC |
bromocriptine mesylate drug variants not containing HYPROMELLOSE 2910
Excipient focus: ISOPROPYL ALCOHOL
bromocriptine mesylate drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | bromocriptine mesylate | 63304-962 |
| Zydus Lifesciences Limited | bromocriptine mesylate | 65841-654 |
| >Company | >Ingredient | >NDC |
bromocriptine mesylate drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LACTOSE
bromocriptine mesylate drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Validus Pharmaceuticals LLC | bromocriptine mesylate | 30698-202 |
| Sun Pharmaceutical Industries Inc | bromocriptine mesylate | 63304-962 |
| Santarus Inc | bromocriptine mesylate | 68012-258 |
| VEROSCIENCE LLC | bromocriptine mesylate | 73515-123 |
| >Company | >Ingredient | >NDC |
bromocriptine mesylate drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
bromocriptine mesylate drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | bromocriptine mesylate | 0781-5325 |
| American Health Packaging | bromocriptine mesylate | 60687-286 |
| Zydus Lifesciences Limited | bromocriptine mesylate | 65841-654 |
| Zydus Pharmaceuticals USA Inc | bromocriptine mesylate | 68382-110 |
| >Company | >Ingredient | >NDC |
bromocriptine mesylate drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
bromocriptine mesylate drug variants containing MAGNESIUM STEARATE
bromocriptine mesylate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MALEIC ACID
bromocriptine mesylate drug variants containing MALEIC ACID
bromocriptine mesylate drug variants not containing MALEIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Santarus Inc | bromocriptine mesylate | 68012-258 |
| VEROSCIENCE LLC | bromocriptine mesylate | 73515-123 |
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
bromocriptine mesylate drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Lifesciences Limited | bromocriptine mesylate | 65841-654 |
| Zydus Pharmaceuticals USA Inc | bromocriptine mesylate | 68382-110 |
| >Company | >Ingredient | >NDC |
bromocriptine mesylate drug variants not containing POTASSIUM HYDROXIDE
Excipient focus: POVIDONE
bromocriptine mesylate drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | bromocriptine mesylate | 0781-5325 |
| Validus Pharmaceuticals LLC | bromocriptine mesylate | 30698-202 |
| American Health Packaging | bromocriptine mesylate | 60687-286 |
| Sun Pharmaceutical Industries Inc | bromocriptine mesylate | 63304-962 |
| >Company | >Ingredient | >NDC |
bromocriptine mesylate drug variants not containing POVIDONE
Excipient focus: POVIDONE K25
bromocriptine mesylate drug variants containing POVIDONE K25
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | bromocriptine mesylate | 0574-0106 |
| Carilion Materials Management | bromocriptine mesylate | 68151-1305 |
| >Company | >Ingredient | >NDC |
bromocriptine mesylate drug variants not containing POVIDONE K25
Excipient focus: PROPYLENE GLYCOL
bromocriptine mesylate drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | bromocriptine mesylate | 0378-7096 |
| Zydus Lifesciences Limited | bromocriptine mesylate | 65841-654 |
| Zydus Pharmaceuticals USA Inc | bromocriptine mesylate | 68382-110 |
| >Company | >Ingredient | >NDC |
bromocriptine mesylate drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
bromocriptine mesylate drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | bromocriptine mesylate | 0378-7096 |
| Zydus Lifesciences Limited | bromocriptine mesylate | 65841-654 |
| Zydus Pharmaceuticals USA Inc | bromocriptine mesylate | 68382-110 |
| >Company | >Ingredient | >NDC |
bromocriptine mesylate drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
bromocriptine mesylate drug variants containing SILICON DIOXIDE
bromocriptine mesylate drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | bromocriptine mesylate | 0378-2042 |
| Mylan Pharmaceuticals Inc | bromocriptine mesylate | 0378-7096 |
| Physicians Total Care Inc | bromocriptine mesylate | 54868-5667 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
bromocriptine mesylate drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | bromocriptine mesylate | 0378-2042 |
| Mylan Pharmaceuticals Inc | bromocriptine mesylate | 0378-7096 |
| Physicians Total Care Inc | bromocriptine mesylate | 54868-5667 |
| >Company | >Ingredient | >NDC |
bromocriptine mesylate drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: STARCH, CORN
bromocriptine mesylate drug variants containing STARCH, CORN
bromocriptine mesylate drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Lifesciences Limited | bromocriptine mesylate | 65841-654 |
| Zydus Pharmaceuticals USA Inc | bromocriptine mesylate | 68382-110 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
bromocriptine mesylate drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | bromocriptine mesylate | 0378-7096 |
| Zydus Lifesciences Limited | bromocriptine mesylate | 65841-654 |
| Zydus Pharmaceuticals USA Inc | bromocriptine mesylate | 68382-110 |
| >Company | >Ingredient | >NDC |
bromocriptine mesylate drug variants not containing TITANIUM DIOXIDE
Excipient focus: WATER
bromocriptine mesylate drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Lifesciences Limited | bromocriptine mesylate | 65841-654 |
| Zydus Pharmaceuticals USA Inc | bromocriptine mesylate | 68382-110 |
| >Company | >Ingredient | >NDC |
bromocriptine mesylate drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
